 | • レポートコード：B-GIR08C4953 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、リウマチ性障害薬の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、等に区分しました。リウマチ性障害薬の世界市場概観、企業動向、企業別リウマチ性障害薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・リウマチ性障害薬の市場概観 ・リウマチ性障害薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・リウマチ性障害薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・リウマチ性障害薬の世界市場規模 ・リウマチ性障害薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・リウマチ性障害薬のアメリカ市場規模推移 ・リウマチ性障害薬のカナダ市場規模推移 ・リウマチ性障害薬のメキシコ市場規模推移 ・リウマチ性障害薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・リウマチ性障害薬のドイツ市場規模推移 ・リウマチ性障害薬のイギリス市場規模推移 ・リウマチ性障害薬のロシア市場規模推移 ・リウマチ性障害薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・リウマチ性障害薬の日本市場規模推移 ・リウマチ性障害薬の中国市場規模推移 ・リウマチ性障害薬の韓国市場規模推移 ・リウマチ性障害薬のインド市場規模推移 ・リウマチ性障害薬の東南アジア市場規模推移 ・リウマチ性障害薬の南米市場分析（ブラジル、アルゼンチン等） ・リウマチ性障害薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・リウマチ性障害薬の種類別分析/販売量、売上、市場シェア（） ・リウマチ性障害薬の用途別分析/市場規模（） ・リウマチ性障害薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・リウマチ性障害薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Treatment of drugs for regulating rheumatic diseases
Scope of the Report:
Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is ongoing and there are no treatments for any of the key indications, so there is a need to develop better disease modulating drugs.
The global Rheumatic Disorders Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatic Disorders Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rheumatic Disorders Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatic Disorders Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
AbbVie
Amgen
Johnson & Johnson
Novartis
Pfizer
Roche
Eli Lilly
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Acting on Tumor Necrosis Factor-Alpha
Acting on Interleukins and Interleukin Receptors
Acting on Protein Kinases
Acting on Cell Surface Antigens
Acting on Hormones and Hormone Receptors
Others
Market Segment by Applications, can be divided into
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Systemic Lupus Erythematosus
Psoriatic Arthritis
Others
Table of Contents
1 Rheumatic Disorders Drug Market Overview
1.1 Product Overview and Scope of Rheumatic Disorders Drug
1.2 Classification of Rheumatic Disorders Drug by Types
1.2.1 Global Rheumatic Disorders Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Rheumatic Disorders Drug Revenue Market Share by Types in 2018
1.2.3 Acting on Tumor Necrosis Factor-Alpha
1.2.4 Acting on Interleukins and Interleukin Receptors
1.2.5 Acting on Protein Kinases
1.2.6 Acting on Cell Surface Antigens
1.2.7 Acting on Hormones and Hormone Receptors
1.2.8 Others
1.3 Global Rheumatic Disorders Drug Market by Application
1.3.1 Global Rheumatic Disorders Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Osteoporosis
1.3.5 Systemic Lupus Erythematosus
1.3.6 Psoriatic Arthritis
1.3.7 Others
1.4 Global Rheumatic Disorders Drug Market by Regions
1.4.1 Global Rheumatic Disorders Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rheumatic Disorders Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatic Disorders Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatic Disorders Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rheumatic Disorders Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatic Disorders Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Rheumatic Disorders Drug (2014-2024)
2 Company Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Rheumatic Disorders Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Rheumatic Disorders Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Rheumatic Disorders Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Rheumatic Disorders Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Rheumatic Disorders Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Rheumatic Disorders Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Rheumatic Disorders Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Rheumatic Disorders Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rheumatic Disorders Drug Market Competition, by Players
3.1 Global Rheumatic Disorders Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatic Disorders Drug Players Market Share
3.2.2 Top 10 Rheumatic Disorders Drug Players Market Share
3.3 Market Competition Trend
4 Global Rheumatic Disorders Drug Market Size by Regions
4.1 Global Rheumatic Disorders Drug Revenue and Market Share by Regions
4.2 North America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
4.5 South America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
5 North America Rheumatic Disorders Drug Revenue by Countries
5.1 North America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
5.2 USA Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
6 Europe Rheumatic Disorders Drug Revenue by Countries
6.1 Europe Rheumatic Disorders Drug Revenue by Countries (2014-2019)
6.2 Germany Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
6.3 UK Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
6.4 France Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rheumatic Disorders Drug Revenue by Countries
7.1 Asia-Pacific Rheumatic Disorders Drug Revenue by Countries (2014-2019)
7.2 China Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
7.5 India Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
8 South America Rheumatic Disorders Drug Revenue by Countries
8.1 South America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
8.2 Brazil Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rheumatic Disorders Drug by Countries
9.1 Middle East and Africa Rheumatic Disorders Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
10 Global Rheumatic Disorders Drug Market Segment by Type
10.1 Global Rheumatic Disorders Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Rheumatic Disorders Drug Market Forecast by Type (2019-2024)
10.3 Acting on Tumor Necrosis Factor-Alpha Revenue Growth Rate (2014-2024)
10.4 Acting on Interleukins and Interleukin Receptors Revenue Growth Rate (2014-2024)
10.5 Acting on Protein Kinases Revenue Growth Rate (2014-2024)
10.6 Acting on Cell Surface Antigens Revenue Growth Rate (2014-2024)
10.7 Acting on Hormones and Hormone Receptors Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Rheumatic Disorders Drug Market Segment by Application
11.1 Global Rheumatic Disorders Drug Revenue Market Share by Application (2014-2019)
11.2 Rheumatic Disorders Drug Market Forecast by Application (2019-2024)
11.3 Rheumatoid Arthritis Revenue Growth (2014-2019)
11.4 Osteoarthritis Revenue Growth (2014-2019)
11.5 Osteoporosis Revenue Growth (2014-2019)
11.6 Systemic Lupus Erythematosus Revenue Growth (2014-2019)
11.7 Psoriatic Arthritis Revenue Growth (2014-2019)
11.8 Others Revenue Growth (2014-2019)
12 Global Rheumatic Disorders Drug Market Size Forecast (2019-2024)
12.1 Global Rheumatic Disorders Drug Market Size Forecast (2019-2024)
12.2 Global Rheumatic Disorders Drug Market Forecast by Regions (2019-2024)
12.3 North America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
12.4 Europe Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
12.6 South America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Rheumatic Disorders Drug Picture
Table Product Specifications of Rheumatic Disorders Drug
Table Global Rheumatic Disorders Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Rheumatic Disorders Drug Revenue Market Share by Types in 2018
Figure Acting on Tumor Necrosis Factor-Alpha Picture
Figure Acting on Interleukins and Interleukin Receptors Picture
Figure Acting on Protein Kinases Picture
Figure Acting on Cell Surface Antigens Picture
Figure Acting on Hormones and Hormone Receptors Picture
Figure Others Picture
Table Global Rheumatic Disorders Drug Revenue (Million USD) by Application (2014-2024)
Figure Rheumatic Disorders Drug Revenue Market Share by Applications in 2018
Figure Rheumatoid Arthritis Picture
Figure Osteoarthritis Picture
Figure Osteoporosis Picture
Figure Systemic Lupus Erythematosus Picture
Figure Psoriatic Arthritis Picture
Figure Others Picture
Table Global Market Rheumatic Disorders Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Rheumatic Disorders Drug Type and Applications
Table AbbVie Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Rheumatic Disorders Drug Type and Applications
Table Amgen Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Rheumatic Disorders Drug Type and Applications
Table Johnson & Johnson Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Rheumatic Disorders Drug Type and Applications
Table Novartis Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Rheumatic Disorders Drug Type and Applications
Table Pfizer Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Rheumatic Disorders Drug Type and Applications
Table Roche Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Rheumatic Disorders Drug Type and Applications
Table Eli Lilly Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Rheumatic Disorders Drug Type and Applications
Table Bristol-Myers Squibb Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rheumatic Disorders Drug Revenue (Million USD) by Players (2014-2019)
Table Global Rheumatic Disorders Drug Revenue Share by Players (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Share by Players in 2017
Figure Global Rheumatic Disorders Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Rheumatic Disorders Drug Revenue Market Share in 2018
Figure Global Top 10 Players Rheumatic Disorders Drug Revenue Market Share in 2018
Figure Global Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rheumatic Disorders Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Rheumatic Disorders Drug Revenue Market Share by Regions (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Market Share by Regions (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Market Share by Regions in 2018
Figure North America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Europe Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure South America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table North America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
Table North America Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure North America Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure North America Rheumatic Disorders Drug Revenue Market Share by Countries in 2018
Figure USA Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Canada Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table Europe Rheumatic Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Rheumatic Disorders Drug Revenue Market Share by Countries in 2018
Figure Germany Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure UK Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure France Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Russia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Italy Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rheumatic Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rheumatic Disorders Drug Revenue Market Share by Countries in 2018
Figure China Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Japan Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Korea Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure India Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table South America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
Table South America Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure South America Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure South America Rheumatic Disorders Drug Revenue Market Share by Countries in 2018
Figure Brazil Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rheumatic Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rheumatic Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rheumatic Disorders Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure UAE Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
Table Global Rheumatic Disorders Drug Revenue (Million USD) by Type (2014-2019)
Table Global Rheumatic Disorders Drug Revenue Share by Type (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Share by Type (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Share by Type in 2018
Table Global Rheumatic Disorders Drug Revenue Forecast by Type (2019-2024)
Figure Global Rheumatic Disorders Drug Market Share Forecast by Type (2019-2024)
Figure Global Acting on Tumor Necrosis Factor-Alpha Revenue Growth Rate (2014-2019)
Figure Global Acting on Interleukins and Interleukin Receptors Revenue Growth Rate (2014-2019)
Figure Global Acting on Protein Kinases Revenue Growth Rate (2014-2019)
Figure Global Acting on Cell Surface Antigens Revenue Growth Rate (2014-2019)
Figure Global Acting on Hormones and Hormone Receptors Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Rheumatic Disorders Drug Revenue by Application (2014-2019)
Table Global Rheumatic Disorders Drug Revenue Share by Application (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Share by Application (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue Share by Application in 2018
Table Global Rheumatic Disorders Drug Revenue Forecast by Application (2019-2024)
Figure Global Rheumatic Disorders Drug Market Share Forecast by Application (2019-2024)
Figure Global Rheumatoid Arthritis Revenue Growth Rate (2014-2019)
Figure Global Osteoarthritis Revenue Growth Rate (2014-2019)
Figure Global Osteoporosis Revenue Growth Rate (2014-2019)
Figure Global Systemic Lupus Erythematosus Revenue Growth Rate (2014-2019)
Figure Global Psoriatic Arthritis Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Rheumatic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rheumatic Disorders Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rheumatic Disorders Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
Figure Europe Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
Figure South America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
世界の遺伝性疾患薬市場2019 The global Genetic Disorders Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Genetic Disorders Drug market status and forecast, categorizes the global Genetic Disorders Drug market size…- 血圧障害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Blood pressure disorder drug development technology and related units Scope of the Report: High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and sa…
- 世界のリウマチ熱治療市場：市場規模・現状・予測 Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition.G…
- 世界のリウマチ性心疾患市場：市場規模・現状・予測 Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expend…
- 世界の長時間作用型注射剤市場：市場規模・現状・予測 Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks in…